TRLV
Trulieve Cannabis Corp.
10.40$
-3.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|
| 17.2% | 28.4% | 26.6% | 20.2% | 19.4% | 19.6% | 21.5% | |
| 14.5% | 14.3% | 15.1% | 14.9% | 15.3% | 14.4% | 14.9% | |
| 1.3% | 2.2% | 2.0% | 1.4% | 1.4% | 2.5% | 1.8% | |
| 12.0% | 15.3% | 19.0% | 17.6% | 3.8% | 4.4% | 11.3% | |
| 7.0% | 5.4% | 5.7% | 2.4% | 4.7% | 7.8% | 5.1% | |
| – | -2.7% | -5.3% | -2.0% | -4.6% | -27.6% | -9.6% | |
| -0.6% | -1.2% | -0.7% | -131.6% | 20.5% | -0.6% | -29.1% | |
| -1.5% | -1.9% | -1.7% | -87.1% | 19.1% | -2.1% | -18.5% | |
| 30.1% | 23.7% | 19.6% | -68.9% | 33.9% | -10.1% | -6.6% | |
| 10.2% | 23.0% | 20.9% | 17.8% | 14.7% | 11.8% | 16.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.